Scan Ryan Specialty Holdings' latest buyback and dividend moves against peers by reviewing our curated list of 29 resilient stocks with low risk scores featuring consistent capital return profiles.
To own Ryan Specialty Holdings, you need to believe its fee based specialty model can keep pulling more E&S, delegated authority, and reinsurance volume through the platform, while holding margins against competition and macro pressure in builder’s risk. The recent earnings and completed buyback strengthen that case in the near term, but they do not remove exposure to weaker construction activity or funding costs.
The main near term swing factor remains how effectively Ryan Specialty Holdings turns segment momentum in areas like Ryan Re, Tera Underwriters, and renewables into steady fee income. The biggest risk still sits in a mix of softer builder’s risk demand, pressure in delegated authority binding, and debt that is not well covered by operating cash flow.
The earnings announcement on October 29, 2026 is the most useful reference point. Management reported third quarter revenue of US$789.96 million and net income of US$88.05 million, with both revenue and net income higher than the same quarter a year earlier. Basic and diluted EPS from continuing operations were US$0.30 and US$0.29 respectively, which supports the narrative around improving profitability and scale.
For you, this update ties directly into the catalysts and risks already in play. Better reported earnings and higher EPS give Ryan Specialty Holdings more room to handle interest expense and still invest behind Ryan Re, Tera Underwriters, and AI tools. Any slowdown in builder’s risk or compression in delegated authority fees would quickly test how durable that earnings profile really is.
Analysts currently assume Ryan Specialty Holdings' revenue will grow at 7.7% a year and that earnings will rise from US$99.0 million today to US$660.2 million by 2029, an increase of about US$561 million. This implies forecast 2029 revenue of US$4.0b and earnings of US$660.2 million.
Uncover why Ryan Specialty Holdings' fair value indicates a 3% potential upside to its current price that may not last much longer.
One alternate view leans heavily on interest costs. Bearish analysts worry that roughly US$226 million of annual net interest expense could squeeze Ryan Specialty Holdings if softer commercial P&C markets persist, even after this buyback and dividend news. Before this update, the most cautious models were only penciling in about US$3.9b of 2029 revenue and US$578.6 million of earnings. As new information filters through, those narratives may change, so it is important to weigh different viewpoints for yourself.
Explore 3 other Ryan Specialty Holdings fair value estimates, including one that suggests as much as 42% downside from the current price!
Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.
Once you have a handle on Ryan Specialty Holdings, it can help to widen the lens and compare it with other companies that match your risk tolerance and return goals using the Simply Wall St Screener.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com